肾上腺功能不全患者围手术期糖皮质激素治疗:基于药代动力学数据的给药方案
研究测定22名健康受试者及68名肾上腺功能不全患者围手术期氢化可的松的药代动力学,发现术后皮质醇半衰期延长、清除率降低,据此制定的新方案(术前口服20mg,术中及术后24小时每6小时静脉25mg,次日每6小时15mg)可使术中及术后48小时皮质醇谷值处于或常高于无肾上腺功能障碍患者围手术期水平,提示可安全使用较低剂量氢化可的松。
要点
- 健康受试者接受较高剂量氢化可的松时皮质醇半衰期更长(2.02±0.15 vs 1.81±0.11小时,P<0.01)。
- 肾上腺功能不全患者相同剂量下皮质醇半衰期长于健康受试者,第二次注射后进一步延长。
- 新方案下术后48小时皮质醇谷值处于或常高于无肾上腺功能障碍患者围手术期水平。
核心结论
- 术后皮质醇药代动力学发生改变,提示肾上腺功能不全患者接受大手术时可安全给予较低剂量氢化可的松。
- 本研究结果对当前应激状态下给予过多糖皮质激素补充的实践提出质疑。
研究设计与样本
- 研究测定22名地塞米松抑制的健康受试者连续两次静脉给予氢化可的松(每6小时15或25mg)的半衰期、清除率和分布容积,并据此制定新方案治疗68名需手术的肾上腺功能不全患者。
主要发现
- 健康受试者中,较高剂量氢化可的松组皮质醇半衰期长于较低剂量组(2.02±0.15 vs 1.81±0.11小时,P<0.01)。
- 肾上腺功能不全患者相同氢化可的松剂量下皮质醇半衰期长于健康受试者。
- 两群体中第二次激素注射后皮质醇半衰期进一步延长。
- 皮质醇半衰期延长源于氢化可的松清除率降低和分布容积增加。
- 术后48小时测定的皮质醇谷值处于无肾上腺功能障碍患者围手术期观察值范围内,且常超过后者。
关键数值与推荐
- 患者插管前2至4小时口服氢化可的松20mg,随后24小时内每6小时静脉给予25mg,第二日每6小时给予15mg。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Perioperative glucocorticoid therapy for patients with adrenal insufficiency (AI) is currently based on anecdotal reports, without supporting pharmacokinetic data. METHODS: We determined the half-life, clearance, and volume of distribution of 2 consecutive intravenously (IV)-administered doses of hydrocortisone (15 or 25 mg every 6 hours) to 22 dexamethasone-suppressed healthy individuals and used the data to develop a novel protocol to treat 68 patients with AI who required surgical procedures. Patients received 20 mg of hydrocortisone orally 2 to 4 hours before intubation and were started on 25 mg of IV hydrocortisone every 6 hours for 24 hours and 15 mg every 6 hours during the second day. Nadir cortisol concentrations were repeatedly measured during that period. RESULTS: In healthy individuals, cortisol half-life was longer when the higher hydrocortisone dose was administered (2.02 ± 0.15 vs 1.81 ± 0.11 hours; P < 0.01), and in patients with AI, the half-life was longer than in healthy individuals given the same hydrocortisone dose. In both populations, the cortisol half-life increased further with the second hormone injection. Prolongation of cortisol half-life was due to decreased hydrocortisone clearance and an increase in its volume of distribution. Nadir cortisol levels determined throughout the 48 postoperative hours were within the range of values and often exceeded those observed perioperatively in patients without adrenal dysfunction. CONCLUSIONS: Cortisol pharmacokinetics are altered in the postoperative period and indicate that lower doses of hydrocortisone can be safely administered to patients with AI undergoing major surgery. The findings of this investigation call into question the current practice of administering excessive glucocorticoid supplementation during stress.
引用
- Arafah BM. Perioperative Glucocorticoid Therapy for Patients with Adrenal Insufficiency: Dosing Based on Pharmacokinetic Data. J Clin Endocrinol Metab. 2020. PMID: 31996925. doi:10.1210/clinem/dgaa042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。